Many ALS or Locked-in patients are unable to interact with their surroundings or communicate as they have lost the ability to control voluntary muscles including facial and vocal muscles. Being locked-in means a patient is quadriplegic, and completely unable to move but mentally 100% alert. The prognosis for these patients is poor and quality of life low as they are unable to function independently and can’t communicate. Locked-in can be caused by ALS, trauma, brainstem stroke or acute muscle disorders, but is often difficult to diagnose.
Global Brain Computer Interface (BCI) Market is expected to reach USD 1.7 billion by 2022. Increasing incidences of neurodegenerative conditions, advancements in neuroscience, rising geriatric population base and the growing demand for neuroprosthetics are some impact rendering drivers of the brain computer interface market.
MindAffect has developed a brain computer interface (BCI) that allows ALS or locked-in patients to interact or communicate by controlling a computer with brain signals. Patients wear an EEG cap that measures electrical brain activity. Through directing their attention at specifically designed stimulus, such as a special keyboard, the BCI matches the brain signals with the stimulus and thus allows a patient to spell per letter. This method is fast, reliable and requires no training.
Currently, there are a number of prototypes in the field and a supported version will be available in the near future.
Meet the team
Bert Arjan Millenaar
Venture Partner at NLC
Bert-Arjan is the founder of NLC and has a personal aim to advance health. He has over 20 years of experience in business development and growth strategies. His love for pushing boundaries and stretching the possibilities of an organisation allows Bert-Arjan to steer NLC's unique business model and to support the team.